mcc-555 has been researched along with pioglitazone in 3 studies
Studies (mcc-555) | Trials (mcc-555) | Recent Studies (post-2010) (mcc-555) | Studies (pioglitazone) | Trials (pioglitazone) | Recent Studies (post-2010) (pioglitazone) |
---|---|---|---|---|---|
26 | 0 | 5 | 4,338 | 824 | 2,277 |
Protein | Taxonomy | mcc-555 (IC50) | pioglitazone (IC50) |
---|---|---|---|
CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | 1 | |
Bile salt export pump | Rattus norvegicus (Norway rat) | 2 | |
Peroxisome proliferator-activated receptor gamma | Rattus norvegicus (Norway rat) | 0.7 | |
Bile salt export pump | Homo sapiens (human) | 0.337 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 0.114 | |
Steryl-sulfatase | Homo sapiens (human) | 0.8 | |
Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | 1.15 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.298 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 3.0379 | |
Peroxisome proliferator-activated receptor gamma | Mus musculus (house mouse) | 0.7 | |
CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | 4.8 | |
CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 8.65 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kadowaki, T | 1 |
Blay, J; Richard, CL | 1 |
Giaginis, C; Theocharis, S; Tsantili-Kakoulidou, A | 1 |
1 review(s) available for mcc-555 and pioglitazone
Article | Year |
---|---|
[Insulin-sensitizing agents].
Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Isoxazoles; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones | 1999 |
2 other study(ies) available for mcc-555 and pioglitazone
Article | Year |
---|---|
Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Pioglitazone; PPAR gamma; Receptors, CXCR4; Rosiglitazone; Thiazolidinediones | 2007 |
Investigation of the lipophilic behaviour of some thiazolidinediones. Relationships with PPAR-gamma activity.
Topics: Chromans; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Lipids; Membranes, Artificial; Octanols; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Troglitazone; Water | 2007 |